Biodistribution and safety assessment of AAV2-GAD following intrasubthalamic injection in the rat

par Fitzsimons, Helen L., Riban, Veronique, Bland, Ross J., Wendelken, Jennifer L., Sapan, Christine V., During, Matthew J.
Publié 2010

Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

par Mascola, John R., Lewis, Mark G., Stiegler, Gabriela, Harris, Dawn, VanCott, Thomas C., Hayes, Deborah, Louder, Mark K., Brown, Charles R., Sapan, Christine V., Frankel, Sarah S., Lu, Yichen, Robb, Merlin L., Katinger, Hermann, Birx, Deborah L.
Publié 1999

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease

par Niethammer, Martin, Tang, Chris C., LeWitt, Peter A., Rezai, Ali R., Leehey, Maureen A., Ojemann, Steven G., Flaherty, Alice W., Eskandar, Emad N., Kostyk, Sandra K., Sarkar, Atom, Siddiqui, Mustafa S., Tatter, Stephen B., Schwalb, Jason M., Poston, Kathleen L., Henderson, Jaimie M., Kurlan, Roger M., Richard, Irene H., Sapan, Christine V., Eidelberg, David, During, Matthew J., Kaplitt, Michael G., Feigin, Andrew
Publié dans JCI Insight (2017)